Net Clinical Benefit of Left Atrial Appendage Closure Versus Warfarin in Patients With Atrial Fibrillation: A Pooled Analysis of the Randomized PROTECT‐AF and PREVAIL Studies

BACKGROUND: The PROTECT‐AF (Watchman Left Atrial Appendage Closure Technology for Embolic Protection in Patients With Atrial Fibrillation) and PREVAIL (Evaluation of the Watchman LAA Closure Device in Patients With Atrial Fibrillation Versus Long Term Warfarin Therapy) trials demonstrated noninferio...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:J Am Heart Assoc
Hlavní autoři: Brouwer, Tom F., Whang, William, Kuroki, Kenji, Halperin, Jonathan L., Reddy, Vivek Y.
Médium: Artigo
Jazyk:Inglês
Vydáno: John Wiley and Sons Inc. 2019
Témata:
Original Research
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6912972/
https://ncbi.nlm.nih.gov/pubmed/31752643
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/JAHA.119.013525
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky